China Healthcare Research
Comprehensive research reports analyzing China's healthcare transformation from 2021 to 2026. Covering universal coverage, AI innovation, medical tourism, biopharmaceuticals, and more.
A comprehensive overview of China’s healthcare transformation from a global participant to a leading innovator and critical hub for medical advancements.
Analysis of China's healthcare infrastructure, universal coverage expansion, and the three-tiered delivery system serving over 1.4 billion people.
The world's first AI hospital, 42 AI doctors across 21 specialties, and China's comprehensive strategy to lead global AI-enabled medical innovation by 2030.
Boao Lecheng International Medical Tourism Pilot Zone achieved 865,300 visits (+109% YoY), with 180+ global companies and unique regulatory advantages.
China ranks #2 globally in clinical trial volume (25%), with accelerated drug approval processes and major advances in CAR-T, antibody-drug conjugates, and novel biologics.
Chinese manufacturers like United Imaging and Mindray developing AI-integrated CT, MRI systems, with 3,000+ internet hospitals and smart surgical robotics.
Addressing the urban-rural health gap with the 2024 Rural Health Roadmap targeting substantial improvements by 2030 and healthcare parity by 2035.
AI-enhanced TCM diagnostics, moxibustion robots, and the integration of traditional medicine with modern healthcare protocols and international promotion.
Intelligent epidemiological investigation systems, AI-powered disease surveillance, and comprehensive chronic disease management strategies post-COVID.
Government health expenditure at 7.2% of GDP, volume-based procurement reforms, and the evolution of China's multi-tiered medical insurance system.
5.07 million licensed doctors (+81.5% since 2013), enhanced medical education, and strategies to address rural practitioner shortages.
Exploring China's shift from "fast-follower" to global innovator in cell therapies, gene editing, and antibody-drug conjugates (ADCs).
Strategic projections for China's healthcare evolution including universal AI adoption, continued insurance expansion, and emerging technology integration.
Digital technologies and AI are transforming China's healthcare, from AI-powered diagnostics to "Agent Hospitals" and nation-wide health platforms.
How China became the #2 global destination for clinical trials, offering unprecedented recruitment speed and regulatory efficiency.
Exploring the Boao Lecheng phenomenon and China's growing appeal to international patients seeking advanced therapies, wellness, and cost-effective care.